Abstract:Background: Current prostate cancer evaluation can be inaccurate and burdensome. Quantitative evaluation of Magnetic Resonance Imaging (MRI) sequences non-invasively helps prostate tumor assessment. However, including Dynamic Contrast Enhancement (DCE) in the examined MRI sequence set can add complications, inducing possible side effects from the IV placement or injected contrast material and prolonging scanning time. More accurate quantitative MRI without DCE and artificial intelligence approaches are needed. Purpose: Predict the risk of developing Clinically Significant (Insignificant) prostate cancer CsPCa (CiPCa) and correlate with the International Society of Urologic Pathology (ISUP) grade using processed Signal to Clutter Ratio (SCR) derived from spatially registered bi-parametric MRI (SRBP-MRI) and thereby enhance non-invasive management of prostate cancer. Methods: This pilot study retrospectively analyzed 42 consecutive prostate cancer patients from the PI-CAI data collection. BP-MRI (Apparent Diffusion Coefficient, High B-value, T2) were resized, translated, cropped, and stitched to form spatially registered SRBP-MRI. Efficacy of noise reduction was tested by regularizing, eliminating principal components (PC), and minimizing elliptical volume from the covariance matrix to optimize the SCR. MRI guided biopsy (MRBx), Systematic Biopsy (SysBx), combination (MRBx + SysBx), or radical prostatectomy determined the ISUP grade for each patient. ISUP grade ≥ 2 (<2) was judged as CsPCa (CiPCa). Linear and logistic regression were fitted to ISUP grade and CsPCa/CiPCa SCR. Correlation Coefficients (R) and Area Under the Curves (AUC) for Receiver Operator Curves (ROC) evaluated the performance. Results: High correlation coefficients (R) (>0.55) and high AUC (=1.0) for linear and/or logistic fit from processed SCR and z-score for SRBP-MRI greatly exceed fits using prostate serum antigen, prostate volume, and patient age (R ~ 0.17). Patients assessed with combined MRBx + SysBx and from individual MRI scanners achieved higher R (DR = 0.207+/-0.118) than all patients used in the fits. Conclusions: In the first study, to date, spectral approaches for assessing tumor aggressiveness on SRBP-MRI have been applied and tested and achieved high values of R and exceptional AUC to fit the ISUP grade and CsPCA/CiPCA, respectively.

Uncertainties of calculated Cramér-Rao lower bounds: implications for quantitative MRS

Uncertainty propagation in absolute metabolite quantification for in vivo MRS of the human brain

Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping

Correction of T 1 Effects in Calculation of Relative Recirculation in Ischemic Stroke Patients

Cramér-Rao Bound Optimized Subspace Reconstruction in Quantitative MRI

Deterministic Cramer-Rao Bound for Scanning Radar Sensing.

An Improved Postprocessing Method to Mitigate the Macroscopic Cross-Slice B0 Field Effect on R2* Measurements in the Mouse Brain at 7T

Uncertainty Quantification in SAR Induced by Ultra-High-Field MRI RF Coil via High-Dimensional Model Representation

Simultaneous multi‐transient linear‐combination modeling of MRS data improves uncertainty estimation

Experimental assessment of clinical MRI-induced global SAR distributions in head phantoms

Cramer Rao-Type Bounds for Sparse Bayesian Learning

Perturb-and-MPM: Quantifying Segmentation Uncertainty in Dense Multi-Label CRFs

High spatial resolution dosimetry with uncertainty analysis using Raman micro-spectroscopy readout of radiochromic films

The Simplified Reference Tissue Model: Model Assumption Violations and Their Impact on Binding Potential

Asymptotically Tight Bayesian Cramér-Rao Bound

The gap persistence theorem for quantum multiparameter estimation

Uncertainty quantification of TMS simulations considering MRI segmentation errors

Application of Spectral Algorithm Applied to Spatially Registered Bi-Parametric MRI to Predict Prostate Tumor Aggressiveness: A Pilot Study

Noise‐reduction techniques for 1H‐FID‐MRSI at 14.1 T: Monte Carlo validation and in vivo application

Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences